948 related articles for article (PubMed ID: 17214731)
21. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series.
Singh F; Lebwohl MG
J Am Acad Dermatol; 2004 Oct; 51(4):570-3. PubMed ID: 15389192
[TBL] [Abstract][Full Text] [Related]
22. Folliculotropic mycosis fungoides.
Hunzeker CM; Fangman W; Latkowski JA
Dermatol Online J; 2007 Jan; 13(1):5. PubMed ID: 17511938
[TBL] [Abstract][Full Text] [Related]
23. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of "nonprogressive" small plaque parapsoriasis.
Belousova IE; Vanecek T; Samtsov AV; Michal M; Kazakov DV
J Am Acad Dermatol; 2008 Sep; 59(3):474-82. PubMed ID: 18694680
[TBL] [Abstract][Full Text] [Related]
24. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
Dalle S; Thomas L
Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
[No Abstract] [Full Text] [Related]
25. Bexarotene and narrowband ultraviolet B phototherapy combination treatment for mycosis fungoides.
Lokitz ML; Wong HK
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):255-7. PubMed ID: 17986063
[TBL] [Abstract][Full Text] [Related]
26. Folliculotropic mycosis fungoides responding to bexarotene gel.
Walling HW; Swick BL; Gerami P; Scupham RK
J Drugs Dermatol; 2008 Feb; 7(2):169-71. PubMed ID: 18335654
[TBL] [Abstract][Full Text] [Related]
27. [Unilesional plaque-type mycosis fungoides: 3 cases].
Verret JL; Rousselet MC; Peria P
Ann Dermatol Venereol; 1997; 124(8):527-30. PubMed ID: 9740844
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
Papadavid E; Antoniou C; Nikolaou V; Siakantaris M; Vassilakopoulos TP; Stratigos A; Stavrianeas N; Katsambas A
Am J Clin Dermatol; 2008; 9(3):169-73. PubMed ID: 18429646
[TBL] [Abstract][Full Text] [Related]
29. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
McGinnis KS; Shapiro M; Vittorio CC; Rook AH; Junkins-Hopkins JM
Arch Dermatol; 2003 Jun; 139(6):771-5. PubMed ID: 12810509
[TBL] [Abstract][Full Text] [Related]
30. Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene.
Mehlmauer MA
Cutis; 2004 Jun; 73(6):417-20. PubMed ID: 15224787
[TBL] [Abstract][Full Text] [Related]
31. Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate.
Steinhoff M; Beyer M; Roewert-Huber J; Lukowsky A; Assaf C; Sterry W
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S88-91. PubMed ID: 18489056
[TBL] [Abstract][Full Text] [Related]
32. CD8-positive granulomatous mycosis fungoides: a case report with review of the literature.
Ishida M; Hotta M; Takikita-Suzuki M; Kojima F; Okabe H
J Cutan Pathol; 2010 Oct; 37(10):1072-6. PubMed ID: 20579213
[TBL] [Abstract][Full Text] [Related]
33. Large cell transformation mimicking regional lymphomatoid papulosis in a patient with mycosis fungoides.
Nakahigashi K; Ishida Y; Matsumura Y; Kore-Eda S; Ohmori K; Fujimoto M; Yamashita K; Kotani H; Sakurai T; Miyachi Y
J Dermatol; 2008 May; 35(5):283-8. PubMed ID: 18477228
[TBL] [Abstract][Full Text] [Related]
34. Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas.
Feldman RJ; Maize JC
Int J Dermatol; 2007 Jan; 46(1):77-9. PubMed ID: 17214727
[TBL] [Abstract][Full Text] [Related]
35. Mycosis fungoides: cutaneous T-cell lymphoma.
Zaim MT; Grinkemeyer MD
Am Fam Physician; 1991 May; 43(5):1703-7. PubMed ID: 2021105
[TBL] [Abstract][Full Text] [Related]
36. [Granulomatous mycosis fungoides histologically simulating cutaneous sarcoidosis].
Maillard H; Croué A; François S; Verret JL
Ann Dermatol Venereol; 1998 Dec; 125(12):912-5. PubMed ID: 9922868
[TBL] [Abstract][Full Text] [Related]
37. Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
Otremba B
Dermatol Clin; 2008 Jan; 26 Suppl 1():51-2. PubMed ID: 18405188
[No Abstract] [Full Text] [Related]
38. The optimal use of bexarotene in cutaneous T-cell lymphoma.
Gniadecki R; Assaf C; Bagot M; Dummer R; Duvic M; Knobler R; Ranki A; Schwandt P; Whittaker S
Br J Dermatol; 2007 Sep; 157(3):433-40. PubMed ID: 17553039
[TBL] [Abstract][Full Text] [Related]
39. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
40. Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
Talpur R; Duvic M
Clin Lymphoma Myeloma; 2006 May; 6(6):488-92. PubMed ID: 16796781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]